Abstract:Acute sleep deprivation has been shown to affect cerebrospinal fluid and plasma concentrations of biomarkers associated with neurodegeneration, though the mechanistic underpinnings remain unknown. This study compared individuals who, for one night, were either subject to total sleep deprivation or free sleep, (i) examining plasma concentrations of neurodegeneration biomarkers the morning after sleep deprivation or free sleep and (ii) determining how overnight changes in biomarkers plasma concentrations correlate with indices of meningeal lymphatic and glymphatic clearance functions. Plasma concentrations of amyloid-β 40 and 42, phosphorylated tau peptide 181, glial fibrillary acid protein and neurofilament light were measured longitudinally in subjects who from Day 1 to Day 2 either underwent total sleep deprivation (n = 7) or were allowed free sleep (n = 21). The magnetic resonance imaging contrast agent gadobutrol was injected intrathecally, serving as a cerebrospinal fluid tracer. Population pharmacokinetic model parameters of gadobutrol cerebrospinal fluid-to-blood clearance were utilized as a proxy of meningeal lymphatic clearance capacity and intrathecal contrast-enhanced magnetic resonance imaging as a proxy of glymphatic function. After one night of acute sleep deprivation, the plasma concentrations of amyloid-β 40 and 42 were reduced, but not the ratio, and concentrations of the other biomarkers were unchanged. The overnight change in amyloid-β 40 and 42 plasma concentrations in the sleep group correlated significantly with indices of meningeal lymphatic clearance capacity, while this was not seen for the other neurodegeneration biomarkers. However, overnight change in plasma concentrations of amyloid-β 40 and 42 did not correlate with the glymphatic marker. On the other hand, the overnight change in plasma concentration of phosphorylated tau peptide 181 correlated significantly with the marker of glymphatic function in the sleep deprivation group but not in the sleep group. The present data add to the evidence of the role of sleep and sleep deprivation on plasma neurodegeneration concentrations; however, the various neurodegeneration biomarkers respond differently with different mechanisms behind sleep-induced alterations in amyloid-β and tau plasma concentrations. Clearance capacity of meningeal lymphatics seems more important for sleep-induced changes in amyloid-β 40 and 42 plasma concentrations, while glymphatic function seems most important for change in plasma concentration of phosphorylated tau peptide 181 during sleep deprivation. Altogether, the present data highlight diverse mechanisms behind sleep-induced effects on concentrations of plasma neurodegeneration biomarkers.

The Relationship between Sleep Parameters Measured by Polysomnography and Selected Neurotrophic Factors

Interactions between neurotrophins, mood, and physical activity under the conditions of sleep deprivation

The Complex Relationship between Neuromodulators, Circadian Rhythms, and Insomnia in Patients with Obstructive Sleep Apnea

Circadian Rhythm Genes and Their Association with Sleep and Sleep Restriction

Changed Serum Levels of Neurotrophic Factors and Their Correlations with Sleep and Cognition in Patients with Chronic Insomnia Disorder

The Brain-Derived Neurotrophic Factor: Missing Link Between Sleep Deprivation, Insomnia, and Depression

Relationship Between Serum Brain-Derived Neurotrophic Factor and Cognitive Impairment in Children with Sleep-Disordered Breathing

Evaluation of HIF-1 Involvement in the BDNF and ProBDNF Signaling Pathways among Obstructive Sleep Apnea Patients

A study on factors related to sleep disorders and serum BDNF expression levels in patients with primary Sjӧgren's syndrome

0172 Predictive Relationships Between Baseline and Recovery Sleep and Neurobehavioral Measures During Sleep Deprivation

Activity-dependent brain-derived neurotrophic factor expression regulates cortistatin-interneurons and sleep behavior

Relationship Between Brain—derived Neurotrophic Factor and Cognitive Function of Obstructive Sleep Apnea/hypopnea Syndrome Patients

Serum neurotrophin concentrations in polish adolescent girls with anorexia nervosa

Acute sleep deprivation immediately increases serum GDNF, BDNF and VEGF levels in healthy subjects

Objective Sleep Duration is Associated with Cognitive Deficits in Primary Insomnia: BDNF May Play a Role.

Subjective Improvement of Sleep in Insomnia Patients Treated at a Day Rehabilitation Centre After the Use of EEG Neurofeedback Therapy – a Pilot Study

Sleep quality and neural circuit function supporting emotion regulation

Proteomic analysis of rat serum revealed the effects of chronic sleep deprivation on metabolic, cardiovascular and nervous system

Sleep deprivation and neurobehavioral dynamics

Mechanisms behind changes of neurodegeneration biomarkers in plasma induced by sleep deprivation